Os 5 REMÉDIOS para EMAGRECER em 2026 | Médico explica tudo!

The year 2026 promises to revolutionize obesity treatment. In this video, I present five medications that will be game-changers: retatrudide with its impressive 28% weight loss (comparable to bariatric surgery), orfogliprone as the first truly practical oral medication, cagrisema preserving bone mass, survodutide treating fatty liver, and bimagrumab protecting muscle. I based my predictions on phase 3 studies and my clinical analysis. Some are already in the final approval phase and may reach the Brazilian market this year. Share in the comments which medication you found most promising and if you disagree with any point in my analysis. ⏱️GET STRAIGHT TO THE POINT: 00:00 - Introduction: New developments in obesity treatment for 2026 00:47 - Last year's predictions and methodology of the current video 01:27 - First medication: Retatrutide - Results of the Triunf program 02:57 - Second medication: Orfogliprone - The revolutionary oral medication 06:01 - Third medication: Cagrisema - Combination of semaglutide and cagrilintide 07:24 - Fourth medication: Survodutide - Benefits for fatty liver 10:57 - Fifth medication: Bimagrumab - Preservation of muscle mass 13:15 - Final verdict: Summary of promising medications Never self-medicate. If in doubt, consult a doctor you trust. 📃Schedule a consultation with me 📃 https://api.whatsapp.com/send/?phone=... ------------- Presentation: Gustavo Lenci Marques (CRMPR 29443) Specialist in Cardiology (RQE 2923) and Internal Medicine (RQE 17909) Doctor of Internal Medicine Professor at the Federal University of Paraná and the Pontifical Catholic University of Paraná Social Media: Instagram:   / gustavolencimarques   Twitter:   / lencimarques   Edited by: @LukasOEditor